site stats

Cingulate therapeutics llc

WebFounder of Cingulate, Inc., Cingulate Works, Inc. and Cingulate Therapeutics LLC, Matthew N. Brams is an entrepreneur who currently is Chief Medical Officer & Executive Vice President at Cingulate, Inc. and Director & Chief Medical Officer at Cingulate Therapeutics LLC and Chief Medical Officer & Executive Vice President at Cingulate … WebCINGULATE THERAPEUTICS LLC a Delaware limited liability company with registered office at 1901 W 47th Pl., Kansas City, KS 66205 USA (“Licensee”); each a “ Party ” and together the “ Parties ”; and

www.sec.gov

WebJan 1, 2024 · EX-10.10 2 ex10-10.htm . Exhibit 10.10 . AMENDMENT TO EMPLOYMENT AGREEMENT . This AMENDMENT is made and effective as of January 1, 2024 by and between CINGULATE THERAPEUTICS LLC, a Delaware Limited Liability Company, whose principal address is 1901 W. 47 th Place, 3 rd Floor, Kansas City, KS 66205 (the … WebJul 13, 2024 · Should You Buy or Sell Cingulate Stock? Get The Latest CING Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat. ... how far is lincolnton from charlotte https://cedarconstructionco.com

Cingulate Therapeutics Partners with Camargo Pharmaceutical …

WebApr 2, 2024 · Cingulate Therapeutics LLC is a privately held clinical stage biopharmaceutical company focused on the development of new and innovative products utilizing the Company's innovative, precision ... WebFounders Craig Gilgallon, Matthew Brams, Raul Silva, Shane J Schaffer. Operating Status Active. Last Funding Type Venture - Series Unknown. … WebJan 9, 2024 · Cingulate Therapeutics LLC is a privately held clinical stage biopharmaceutical company focused on the development of new and innovative products utilizing the Company's innovative, precision ... high bay microwave motion sensor

Matthew N. Brams - Biography

Category:Cingulate Inc. Announces Pricing of $25.0 Million Initial Public …

Tags:Cingulate therapeutics llc

Cingulate therapeutics llc

Cingulate Therapeutics Presents Results of Pivotal Phase 2 …

WebAmendment to Employment Agreement, effective April 1, 2024, between Cingulate Therapeutics LLC and Raul R. Silva Cingulate Inc. Reports First Quarter 2024 Results and Provides Clinical and Business Update Announcement of First Subject Dosing for Anxiety Candidate CTx-2103 to Extend the Application of the Precision Timed Release™ … WebCingulate, Inc. operates as a clinical stage bio pharmaceutical company using Precision Timed Release, drug delivery platform technology to build a pipeline of next-generation pharmaceutical products.

Cingulate therapeutics llc

Did you know?

WebCingulate. Manufacturing · Kansas, United States · <25 Employees . Cingulate is a clinical stage biopharmaceutical company utilizing its proprietary Precision Timed Release drug …

WebMar 10, 2024 · Cingulate plans to commence two CTx-1301 Phase 3 clinical studies in 2024: (1) a fixed-dose pediatric and adolescent safety and efficacy study, which will … WebExhibit 10.1 . AMENDMENT TO EMPLOYMENT AGREEMENT . This AMENDMENT is made and effective as of April 1, 2024 by and between CINGULATE THERAPEUTICS …

WebCingulate Therapeutics LLC operates as a clinical stage biopharmaceutical company. The Company focuses on the development of products for the treatment of attention deficit … WebSep 23, 2024 · EX-10.7 6 ex10-7.htm . Exhibit 10.7 . EMPLOYMENT AGREEMENT . This AGREEMENT (this “Agreement”) is made and effective as of this 23rd day of September, 2024 by and between CINGULATE THERAPEUTICS LLC, a Delaware Limited Liability Company, whose principal address is 1901 W. 47 th Place, 3 rd Floor, Kansas City, KS …

WebCingulate Therapeutics. Jan 2024 - Present4 years 4 months. Kansas City, Kansas.

WebCingulate Therapeutics, Kansas City, Kansas. 92 likes · 2 were here. Cingulate Therapeutics, LLC (CTx) is a privately held, clinical stage bio-pharmaceutical company foc how far is linden tx from tyler txWebAug 8, 2024 · Cingulate Therapeutics, LLC is a privately held clinical stage biopharmaceutical company focused on the development of new and innovative products for the treatment of Attention Deficit ... high bay occupancy sensor wattstopperWebSep 23, 2024 · EX-10.4 3 ex10-4.htm . Exhibit 10.4 . EMPLOYMENT AGREEMENT . This AGREEMENT (this “Agreement”) is made and effective as of this 23rd day of September, 2024 by and between CINGULATE THERAPEUTICS LLC, a Delaware Limited Liability Company, whose principal address is 1901 W. 47 th Place, 3 rd Floor, Kansas City, KS … how far is lincroft nj from meWebCingulate. Manufacturing · Kansas, United States · <25 Employees . Cingulate is a clinical stage biopharmaceutical company utilizing its proprietary Precision Timed Release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from freq uently diagnosed conditions … high bay mounting hookWebCingulate Inc. 1901 W 47th Place Kansas City, KS 66205 (913) 942-2300 [email protected]. Legal 6 South Street, Suite 203 Morristown, New Jersey 07960. Clinical Trial Investigators [email protected]. Investor Relations Thomas Dalton Head of Investor & Public Relations (913) 942-2301 high bay light vs low bay lightWebCingulate Therapeutics. Jan 2024 - Present4 years 4 months. Kansas City, Kansas. how far is lindfield from tunbridge wellsWebShane J. Schaffer founded Cingulate, Inc., Cingulate Works, Inc. and Cingulate Therapeutics LLC. Presently, Dr. Schaffer holds the position of Chairman & Chief Executive Officer for Cingulate, Inc. and Chairman & Chief Executive Officer of Cingulate Therapeutics LLC and Chairman & Chief Executive Officer of Cingulate Works, Inc. … how far is lindon utah from provo utah